Soham Maity

Over the last few decades, we have observed renaissance in the research of vaccine development, leading to the vaccine against polio, measles, mumps, and rubella. It reaches the summit during the development of COVID-19 vaccine which happened in a record-breaking time, saving millions of lives. As a graduate student, Mr. Maity was enthralled by the research and innovation in vaccine development to meet real public health needs. Iaso therapeutics is devoted towards this goal to treat life-threating diseases including cancer and microbial infection, thus acts as an exciting platform to be part of it. Currently at Iaso, he is interested in developing effective vaccine against Salmonella infection.

A native to India, Mr. Maity received his BSc degree in Chemistry from Jadavpur University. He earned MSc in Chemistry from Indian Institute of Science, Bangalore. He is currently a graduate student at Michigan State University. He joined Iaso in 2022 as an intern. Mr. Maity has expertise in synthetic organic chemistry and chemical biology.